Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency
- PMID: 2104895
Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency
Abstract
This study was designed to simulate purine nucleoside phosphorylase (PNP) deficiency by preincubating with guanosine (Guo) to minimize PNP activity while investigating the metabolism of [14C] deoxyguanosine (dGuo) at physiologic concentrations (10 microM) by unstimulated thymocytes, tonsil-derived T and B lymphocytes, and peripheral blood cells over short time periods. GTP was the principal metabolite formed from dGuo by all cell types with functional PNP and hypoxanthine-guanine phosphoribosyltransferase, confirming formation via degradation to guanine with subsequent salvage by hypoxanthine-guanine phosphoribosyltransferase. Thymocytes also formed a small amount of deoxyguanosine triphosphate (dGTP), presumably through direct phosphorylation by deoxycytidine kinase. Incorporation of dGuo into GTP was effectively inhibited in all instances under PNP deficiency conditions and dGTP levels increased up to 10-fold in thymocytes, but tonsil-derived B or T lymphocytes and unfractionated PBL still accumulated no detectable dGTP. E and platelets formed low amounts of dGTP under these conditions. Preincubation with adenine (50 microM) to reverse any Guo-induced toxicity reduced the incorporation of dGuo into GTP without inhibitor in all cell types with intact adenine phosphoribosyltransferase, but had no effect on dGTP accumulation in thymocytes, with or without inhibitor, thus excluding any indirect formation of dGTP via the de novo route. The rapid metabolism of dGuo to GTP, in the absence of PNP inhibition and subsequent effects of the altered GTP concentrations on cellular metabolism, may account for the differing responses reported by investigators with the use of low dGuo concentrations (enhancing), compared with high (inhibitory), concentrations in mitogen-stimulated lymphocyte studies. The exclusive ability of thymocytes to accumulate significant amounts of dGTP, and inability of B cells to do so, provides a logical explanation for the selective T cell immunodeficiency in PNP deficiency.
Similar articles
-
Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages.Int J Immunopharmacol. 1988;10(6):675-86. doi: 10.1016/0192-0561(88)90021-5. Int J Immunopharmacol. 1988. PMID: 2974022
-
Functional and mechanistic studies on the toxicity of deoxyguanosine for the in vitro proliferation and differentiation of human peripheral blood B lymphocytes.Eur J Immunol. 1986 Apr;16(4):381-7. doi: 10.1002/eji.1830160412. Eur J Immunol. 1986. PMID: 3084280
-
The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B lymphocyte differentiation in vitro.J Immunol. 1984 May;132(5):2318-23. J Immunol. 1984. PMID: 6425400
-
Pharmacology and mechanism of action of forodesine, a T-cell targeted agent.Semin Oncol. 2007 Dec;34(6 Suppl 5):S8-12. doi: 10.1053/j.seminoncol.2007.11.003. Semin Oncol. 2007. PMID: 18086347 Review.
-
[Purine nucleoside phosphorylase (PNP)].Nihon Rinsho. 1996 Dec;54(12):3220-5. Nihon Rinsho. 1996. PMID: 8976095 Review. Japanese.
Cited by
-
Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse.Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2522-7. doi: 10.1073/pnas.94.6.2522. Proc Natl Acad Sci U S A. 1997. PMID: 9122228 Free PMC article.
-
Inborn errors of immunity associated with defects of thymic development.Pediatr Allergy Immunol. 2022 Aug;33(8):e13832. doi: 10.1111/pai.13832. Pediatr Allergy Immunol. 2022. PMID: 36003043 Free PMC article. Review.
-
Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.Ther Clin Risk Manag. 2007 Dec;3(6):1135-41. Ther Clin Risk Manag. 2007. PMID: 18516261 Free PMC article.
-
High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient.Arch Dis Child. 1999 Aug;81(2):179-80. doi: 10.1136/adc.81.2.179. Arch Dis Child. 1999. PMID: 10490534 Free PMC article.
-
Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.J Clin Invest. 1995 Apr;95(4):1660-8. doi: 10.1172/JCI117841. J Clin Invest. 1995. PMID: 7706474 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous